FDA Admits Folding Under Pressure, Will Revoke Approval for Knee Patch

The U.S. Food and Drug Administration has said that it will rescind the approval of the Menaflex patch for injured knees. The agency granted the approval in error, the FDA now says, after being unduly pressured by four New Jersey congressmen and its own commissioner.

Menaflex was substantially different from previous devices, and should have been tested more thoroughly before approval.

According to the New York Times:

“The F.D.A. had never before admitted that it approved a drug or device mistakenly, never rescinded such an approval without citing new information about the product, never admitted that a regulatory decision was influenced by politics, and never accused a former commissioner of questionable conduct.”

+ Sources and References
Post your comment
Click Here and be the first to comment on this article